Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin

Publisher： Karger

E-ISSN： 1662-6575|9|3|840-846

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.3, 2016-12, pp. : 840-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-06 ,pp. : 383-388

Karger

Access to resources Recommend Favorite

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-05 ,pp. : 285-288

Karger

Access to resources Recommend Favorite

A Near-Complete Response to Treatment with Gemcitabine plus nab®-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-10 ,pp. : 711-717

Karger

Access to resources Recommend Favorite

High-Dose Therapy for Breast Cancer – A Case of Suspended Animation

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 248-254

Karger

Access to resources Recommend Favorite

Complete and Sustained Response with a Doublet Chemotherapy Protocol in an 81-Year-Old Patient with Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 580-585

Karger

Access to resources Recommend Favorite